An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis (MS) on Saturday won a prestigious Breakthrough Prize, nicknamed the “Oscars of science.”
Stephen Hauser and Alberto Ascherio were recognized for their decades researching the debilitating neurodegenerative disease, which affects nearly 3 million people worldwide and was long considered an impenetrable enigma.
Hauser’s work on MS started more than 45 years ago, when he met Andrea, “an extraordinarily talented young woman who was already an attorney” and working at the White House under then-US president Jimmy Carter, he said.
Photo: AFP
“Then MS appeared in an explosive fashion and destroyed her life,” he said.
“I remember seeing her, unable to speak, paralyzed on the right side, unable to swallow and soon, unable to breathe on her own, and I remember thinking that this was the most unfair thing I had ever seen in medicine,” he said.
Then 27 years old, he decided to make it his life’s work.
Photo: AFP
“At the time, we had no treatments for MS. In fact, there was also a pessimism that treatments could ever be developed,” said Hauser, now 74 and director of the neuroscience institute at the University of California, San Francisco.
Scientists knew the disease, which damages the central nervous system and leads to paralyzing cognitive and motor problems, was caused by the immune system turning on the body.
However, they thought the white blood cells known as T cells were the lone culprit.
Studying the role played in the disease by B cells, another type of white blood cell, Hauser and his colleagues recreated the damage MS causes to the human nervous system in marmosets.
The US federal body overseeing medical research dismissed the link as “biologically implausible,” and turned down their application for funding for a clinical trial, but Hauser and his team pressed on.
They persuaded pharmaceutical company Genentech to back testing.
In 2006, they found that treatments targeting B cells were associated with “a dramatic, more than 90-percent reduction in brain inflammation,” Hauser said.
That threw open a door to bring new treatments to market that slow the advance of the disease in many people.
However, it raised other questions. For example, what would cause white blood cells to turn against the body?
That puzzled Ascherio, now a professor at Harvard University.
He investigated why MS mostly affected people in the northern hemisphere.
“The geographical distribution of MS was quite striking,” he said. “MS is very uncommon in tropical countries and near the equator.”
He and his team carried out a long-term study following millions of young US military recruits.
After nearly 20 years of research, they came up with an answer. In 2022, they confirmed a link between MS and the Epstein-Barr virus (EBV), a common infection responsible for another well-known disease, infectious mononucleosis, or mono.
“Most people infected with EBV will never develop MS,” but everyone who develops MS has had EBV first, Ascherio, 72, said.
The discovery did not explain why MS occurs, but it fueled hope of finding new treatments and preventive measures for a disease that remains incurable.
Ascherio’s breakthrough could also help treat other conditions.
“We are now trying also to extend our investigation, to investigate the role of viral infection in other neurodegenerative diseases, like Alzheimer’s or amyotrophic lateral sclerosis,” also known as ALS or Lou Gehrig’s disease, he said.
The link remains theoretical, but “there is some evidence,” he said.
“It’s like where we were on MS 20 or 30 years ago,” he added.
Packed crowds in India celebrating their cricket team’s victory ended in a deadly stampede on Wednesday, with 11 mainly young fans crushed to death, the local state’s chief minister said. Joyous cricket fans had come out to celebrate and welcome home their heroes, Royal Challengers Bengaluru, after they beat Punjab Kings in a roller-coaster Indian Premier League (IPL) cricket final on Tuesday night. However, the euphoria of the vast crowds in the southern tech city of Bengaluru ended in disaster, with Indian Prime Minister Narendra calling it “absolutely heartrending.” Karnataka Chief Minister Siddaramaiah said most of the deceased are young, with 11 dead
DENIAL: Musk said that the ‘New York Times was lying their ass off,’ after it reported he used so much drugs that he developed bladder problems Elon Musk on Saturday denied a report that he used ketamine and other drugs extensively last year on the US presidential campaign trail. The New York Times on Friday reported that the billionaire adviser to US President Donald Trump used so much ketamine, a powerful anesthetic, that he developed bladder problems. The newspaper said the world’s richest person also took ecstasy and mushrooms, and traveled with a pill box last year, adding that it was not known whether Musk also took drugs while heading the so-called US Department of Government Efficiency (DOGE) after Trump took power in January. In a
LOST CONTACT: The mission carried payloads from Japan, the US and Taiwan’s National Central University, including a deep space radiation probe, ispace said Japanese company ispace said its uncrewed moon lander likely crashed onto the moon’s surface during its lunar touchdown attempt yesterday, marking another failure two years after its unsuccessful inaugural mission. Tokyo-based ispace had hoped to join US firms Intuitive Machines and Firefly Aerospace as companies that have accomplished commercial landings amid a global race for the moon, which includes state-run missions from China and India. A successful mission would have made ispace the first company outside the US to achieve a moon landing. Resilience, ispace’s second lunar lander, could not decelerate fast enough as it approached the moon, and the company has
By 2027, Denmark would relocate its foreign convicts to a prison in Kosovo under a 200-million-euro (US$228.6 million) agreement that has raised concerns among non-governmental organizations (NGOs) and residents, but which could serve as a model for the rest of the EU. The agreement, reached in 2022 and ratified by Kosovar lawmakers last year, provides for the reception of up to 300 foreign prisoners sentenced in Denmark. They must not have been convicted of terrorism or war crimes, or have a mental condition or terminal disease. Once their sentence is completed in Kosovan, they would be deported to their home country. In